Journal article
Role of bisphosphonates and calcitonin in the prevention and treatment of osteoporosis
Abstract
Bisphosphonates have been shown to increase bone mineral density in patients with established osteoporosis as well as those with osteopenia. The evidence conclusively shows a reduction in fracture rates in patients on the more potent nitrogen containing bisphosphonates. Indeed, significant vertebral fracture rate reduction has been demonstrated after only 1 year of therapy. Alendronate, a second-generation bisphosphonate, and risedronate, a …
Authors
Woo T; Adachi JD
Journal
Best Practice & Research Clinical Rheumatology, Vol. 15, No. 3, pp. 469–481
Publisher
Elsevier
Publication Date
7 2001
DOI
10.1053/berh.2001.0161
ISSN
1521-6942